Skip To Main Content
Sara Barmettler on Muck Rack

Sara Barmettler

As seen in: Wiley Online Library, ScienceDirect, The New England Journal of Medicine, The Journal of Allergy & Clinical Immunology, Annals of Allergy, Asthma & Immunology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sara

Contact Sara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Reductions in Immunoglobulin Levels, Atopic Disease, and Asthma Following CAR T-Cell Therapy

|
By Ahmed Elmoursi, Sara Barmettler
| Annals of Allergy, Asthma & Immunology Verified
KEY WORDS Chimeric Antigen Receptor (CAR) T-Cell Therapy CD19 CAR T Cells BCMA CAR T Cells B-Cell Depletion Immunoglobulins Atopic Disease Asthma Allergic Inflammation Hypogammaglobulinemia Immune Resetting Get full text access Log in, subscribe or purchase for full access. References 1. June CH ∙ O'Connor, R.S. ∙ Kawalekar, O.U. ... CAR T cell immunotherapy for human cancer Science. 2018 Mar 23; 359(6382):1361-1365 PMID: 29567707 2. Müller, F. ∙ Taubmann, J. ∙ Bucci, L. ...
Open in Who Shared Issue with article?

Hypogammaglobulinemia in Children Receiving Targeted Immunotherapies for B Lineage Malignancies: Practical Guidance for Assessment and Management

|
By Adrienne H. Long, Catherine Aftandilian, Sara Barmettler, Sarah Alexander
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. References 1, , , et al., “Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children,” New England Journal of Medicine 392, no. 9 (2025): 875–891. 2, , , et al., “A Phase 3 Trial of Inotuzumab Ozogamicin for High-Risk B-ALL: Second Safety Phase Results From Children's Oncology Group AALL1732,” Journal of Clinical Oncology 41 (2023): 10016–10016.
Open in Who Shared Issue with article?

Implementation of the esophageal string test in clinical practice and research

|
By Sara Barmettler, Naruhito Iwasaki, Atsushi Kato, Natalia M. Sutherland
| ScienceDirect Verified
Supported in part by the /National Institute of Allergy and Infectious Diseases (grant K23AI158813 [to B.L.W.]). Disclosure of potential conflict of interest: S. Schroeder reports being a consultant for , , and EvoEndo and received research funding from Regeneron, Celgene, and AstraZeneca. B. L. Wright reports in-kind support from Regeneron in the form of study drug (dupilumab and placebo) for a clinical trial of milk oral immunotherapy. The remaining
Open in Who Shared Issue with article?
See all 12 articles